Published in Medical Letter on the CDC and FDA, August 6th, 2006
The contract will run for a period of two years with a total contract award amount of $149,110,000.
"Our ultimate goal is to stockpile sufficient quantities of antiviral drugs to treat 25% of the U.S. population," Leavitt said. "Helping the states develop their own medical stockpiles will facilitate quicker distribution of antiviral drugs in the event of a pandemic influenza...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA